• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Opinion

Video

FDA Approved Treatments: Topical Ruxolitinib and Vitiligo Management

Author(s):

Andrea Rosik, PA-C

Related Videos
3 experts are featured in this series.
1 KOL is featured in this program
1 KOL is featured in this program
3 experts are featured in this series.
1 KOL is featured in this program
Ted Lain, MD, MBA, FAAD, is featured in this series.
Ted Lain, MD, MBA, FAAD, is featured in this series.
Ted Lain, MD, MBA, FAAD, is featured in this series.
Related Content
Matthew Zirwas, MD: Cutting-Edge Advances in Atopic Dermatitis and Itch Management
November 15th 2024

Matthew Zirwas, MD: Cutting-Edge Advances in Atopic Dermatitis and Itch Management

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

PDUFA Date for Tapinarof 1% Cream in Atopic Dermatitis Pushed to 2025
November 5th 2024

PDUFA Date for Tapinarof 1% Cream in Atopic Dermatitis Pushed to 2025

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Rademikibart Differentiates From Dupilumab With Optimized IL-4Rα Inhibition and Enhanced Binding Stability
November 1st 2024

Rademikibart Differentiates From Dupilumab With Optimized IL-4Rα Inhibition and Enhanced Binding Stability

Effectiveness of Dupilumab on Special Sites in Atopic Dermatitis
November 1st 2024

Effectiveness of Dupilumab on Special Sites in Atopic Dermatitis

© 2024 MJH Life Sciences

All rights reserved.